Trial
NCT05153408
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Blueprint Medicines Corporation
Collaborators
—
Condition
Lung Neoplasm
Intervention
BLU-701
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-18